Emerging drugs for the treatment of angina pectoris

Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine

(2016) Giuseppe M. C. Rosano et al.   CARDIOVASCULAR DRUGS AND THERAPY

The Who, What, Why, When, How and Where of Vasospastic Angina

(2016) John F. Beltrame et al.   CIRCULATION JOURNAL

Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease

(2016) B. S. M. Chow et al.   CLINICAL SCIENCE

Coronary Microvascular Dysfunction as a Mechanism of Angina in Severe AS

(2016) Jong-Hwa Ahn et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Can Perhexiline Be Utilized Without Long-Term Toxicity? A Clinical Practice Audit

(2016) Helen Phuong et al.   THERAPEUTIC DRUG MONITORING

Angina pectoris in patients without flow-limiting coronary artery disease (cardiac syndrome X). A forest of a variety of trees

(2015) Giuseppe Cocco et al.   Cardiology Journal

Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial

(2015) Jorge A. Gutierrez et al.   CLINICAL CARDIOLOGY

Stereoselective handling of perhexiline: implications regarding accumulation within the human myocardium

(2015) Cher-Rin Chong et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies

(2014) Cristina Varas-Lorenzo et al.   BMC Cardiovascular Disorders

Glucose–insulin–potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials

(2014) Pei-Yin Jin et al.   BMC Cardiovascular Disorders

Pioglitazone, a peroxisome proliferator-activated receptor γ activator, suppresses coronary spasm

(2014) Sumio Morita et al.   CORONARY ARTERY DISEASE

The efficacy of trimetazidine on stable angina pectoris: A meta-analysis of randomized clinical trials

(2014) Song Peng et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Organic nitrates: Update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction

(2014) Thomas Münzel et al.   VASCULAR PHARMACOLOGY

Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis

(2014) Jonathan Belsey et al.   European Journal of Preventive Cardiology

DIGAMI 1: 20 years later

(2014) Denise E Bonds   Lancet Diabetes & Endocrinology

Thioredoxin-Interacting Protein Mediates Sustained VEGFR2 Signaling in Endothelial Cells Required for Angiogenesis

(2013) Shin-Young Park et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Contemporary Use of β-Blockers: Clinical Relevance of Subclassification

(2013) Luc Poirier et al.   CANADIAN JOURNAL OF CARDIOLOGY

Reciprocal regulation of NO signaling and TXNIP expression in humans: Impact of aging and ramipril therapy

(2013) Aaron L. Sverdlov et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina

(2013) Mikhail Kosiborod et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Inhibition of malonyl-CoA decarboxylase reduces the inflammatory response associated with insulin resistance

(2012) Victor Samokhvalov et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Anti-Anginal and Anti-Ischemic Effects of Late Sodium Current Inhibition

(2012) Neil J. Wimmer et al.   CARDIOVASCULAR DRUGS AND THERAPY

Efficacy of Cilostazol on Uncontrolled Coronary Vasospastic Angina: A Pilot Study

(2012) Sang-Yong Yoo et al.   Cardiovascular Therapeutics

Translating the effects of statins: From redox regulation to suppression of vascular wall inflammation

(2012) A. S. Antonopoulos et al.   THROMBOSIS AND HAEMOSTASIS

Efficacy Comparison of Trimetazidine with Therapeutic Alternatives in Stable Angina Pectoris: A Network Meta-Analysis

(2011) Nicolas Danchin et al.   CARDIOLOGY

Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study

(2011) L. G. Mellbin et al.   DIABETOLOGIA

Extrapyramidal adverse drug reactions associated with trimetazidine: a series of 21 cases

(2011) Kamel Masmoudi et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Drug-induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France

(2011) Emmanuelle Bondon-Guitton et al.   MOVEMENT DISORDERS

Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy

(2010) Khalid Abozguia et al.   CIRCULATION

Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?

(2010) J. E. Deanfield et al.   EUROPEAN HEART JOURNAL

Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease

(2010) R. M. Beadle et al.   HEART

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial

(2010) Awsan Noman et al.   LANCET

Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein

(2009) Junqin Chen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion

(2009) John R. Ussher et al.   BASIC RESEARCH IN CARDIOLOGY

Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy

(2008) Helena Tuunanen et al.   CIRCULATION

Angiotensin-Converting-Enzym-Hemmer bei Angina pectoris

(2008) W.-D. Bussmann et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT